← Back to Search

Time-and-Attention Control Session for Human Immunodeficiency Virus Infection

N/A
Waitlist Available
Led By Susan Little, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 24 and 48
Awards & highlights

Summary

This study aims to evaluate two ways to help people re-engage with healthcare. The first is to assess if providing HIV treatment on the first visit (or within 1 week) can help people re-engage with care and ultimately stay in care after 24 and 48 weeks. It will also assess the success of starting treatment immediately by measuring the HIV virus in people's bloodstream after 24 and 48 weeks. The second part of this study is to assess a new behavioral treatment called 60-Minutes-for-Health which aims to help people identify and overcome barriers to HIV care, to help with motivation maintaining in care, to help cope with negative feelings about HIV, and to help increase self-reliance in seeking healthcare amid other things that are happening in your life.

Eligible Conditions
  • HIV (Human Immunodeficiency Virus)
  • Human Immunodeficiency Virus Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 24 and 48
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 24 and 48 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Retention in Care
Secondary outcome measures
ART Initiation
Genotypic susceptibility score comparison
Rapid ART acceptability
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Time-and-Attention Control SessionExperimental Treatment1 Intervention
60 Minute diet \& nutrition control session
Group II: 60-Minutes-For-HealthExperimental Treatment1 Intervention
60-Minutes-for Health: this is a psychological intervention which seeks to correct factors underlying decisions to delay or avoid HIV care and strengthen abilities to overcome HIV care utilization barriers. This is achieved through assistance identifying and reducing misinformation guiding HIV care attendance decisions; enhancing motivation to maintain HIV care via personal health goals; building skills for coping with negative feelings related to living with HIV; and increasing self-efficacy for navigating structural barriers and maintaining HIV care amidst competing priorities.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,157 Previous Clinical Trials
1,571,295 Total Patients Enrolled
Gilead SciencesIndustry Sponsor
1,098 Previous Clinical Trials
860,345 Total Patients Enrolled
Susan Little, MDPrincipal Investigator - UC San Diego AntiViral Research Center (AVRC)
Regents Of The University Of California -Ucsd Physician Assoc, Regents of the University of California - UCSD Medical Group, UC San Diego Health System-Hillcrest, UCSD Medical Center-Hillcrest
Washington University School Of Medicine (Medical School)
Barnes-Jewish Hosp-S Campus (Residency)
3 Previous Clinical Trials
236 Total Patients Enrolled
~24 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top